ALX Oncology Holdings, Inc. (ALXO)
1.17
-0.02
(-1.68%)
USD |
NASDAQ |
Oct 23, 16:00
1.17
0.00 (0.00%)
After-Hours: 20:00
ALX Oncology Holdings Market Cap : 161.71M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 161.71M |
| October 22, 2026 | 164.48M |
| October 21, 2026 | 158.95M |
| October 20, 2026 | 171.39M |
| October 19, 2026 | 157.57M |
| October 16, 2026 | 146.51M |
| October 15, 2026 | 138.22M |
| October 14, 2026 | 123.66M |
| October 13, 2026 | 135.40M |
| October 12, 2026 | 174.15M |
| October 09, 2026 | 172.77M |
| October 08, 2026 | 163.10M |
| October 07, 2026 | 156.18M |
| October 06, 2026 | 153.42M |
| October 05, 2026 | 167.24M |
| October 02, 2026 | 168.62M |
| October 01, 2026 | 179.68M |
| September 30, 2026 | 192.12M |
| September 29, 2026 | 186.59M |
| September 28, 2026 | 192.12M |
| September 25, 2026 | 181.06M |
| September 24, 2026 | 187.28M |
| September 23, 2026 | 203.18M |
| September 22, 2026 | 221.15M |
| September 21, 2026 | 229.44M |
| Date | Value |
|---|---|
| September 18, 2026 | 234.97M |
| September 17, 2026 | 240.50M |
| September 16, 2026 | 243.26M |
| September 15, 2026 | 261.23M |
| September 14, 2026 | 266.07M |
| September 11, 2026 | 268.14M |
| September 10, 2026 | 262.61M |
| September 09, 2026 | 254.32M |
| September 08, 2026 | 276.43M |
| September 04, 2026 | 277.81M |
| September 03, 2026 | 280.58M |
| September 02, 2026 | 287.49M |
| September 01, 2026 | 273.67M |
| August 31, 2026 | 266.76M |
| August 28, 2026 | 276.43M |
| August 27, 2026 | 283.34M |
| August 26, 2026 | 273.67M |
| August 25, 2026 | 276.43M |
| August 24, 2026 | 275.05M |
| August 21, 2026 | 281.96M |
| August 20, 2026 | 275.05M |
| August 19, 2026 | 284.73M |
| August 18, 2026 | 287.49M |
| August 17, 2026 | 272.29M |
| August 14, 2026 | 270.90M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.189B |
| Oncolytics Biotech, Inc. | 62.61M |
| Sangamo Therapeutics, Inc. | 47.64M |
| Sarepta Therapeutics, Inc. | 1.873B |
| Anixa Biosciences, Inc. | 103.41M |
Market Cap Related Metrics
| Price to Book Value | 1.187 |
| Price | 1.17 |
| Earnings Yield | -97.27% |